Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Related stocks: Pharmaceutical Preparations
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Our Corporate History and Background The Company (formerly known as Selecta Biosciences, Inc., or Selecta) was incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland. On November 13, 2023, the Company and the Delaware corporation which, immediately prior to the Merger (as defined below), was known as Cartesian Therapeutics, Inc., or Old Cartesian, entered int…
The business is unprofitable at the operating level (-5127.10% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 92.8% YoY. Margins deteriorated 5014.3pp alongside, both lines moving the wrong way.
Negative free cash flow of -$79M. The business is consuming cash, not generating it. Operating margin contracted 5014.3pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$2M
▼ -92.8% YoY
Net Income (TTM)
-$152M
▼ -68.3% YoY
Op. Margin
-8338.87%
▼ -5014.3pp YoY
ROIC
-926.50%
Cash Flow & Balance Sheet
FCF (TTM)
-$77M
▼ -142.3% YoY
Op. Cash Flow (TTM)
-$73M
▼ -212.3% YoY
Net Debt
-$107M
Net Cash Position
Cash & Equiv.
$119M
5Y CAGR: -30.0%
Continue Research